Literature DB >> 24356778

Passive smoking exposure is associated with increased risk of COPD in never smokers.

Stig Hagstad1, Anders Bjerg2, Linda Ekerljung3, Helena Backman4, Anne Lindberg5, Eva Rönmark5, Bo Lundbäck2.   

Abstract

BACKGROUND: Passive smoking, or environmental tobacco smoke (ETS), is a risk factor for lung cancer, cardiovascular disease, and childhood asthma, but a relationship with COPD has not been fully established. Our aim was to study ETS as a risk factor for COPD in never smokers.
METHODS: Data from three cross-sectional studies within the Obstructive Lung Disease in Northern Sweden (OLIN) database were pooled. Of the 2,182 lifelong never smokers, 2,118 completed structured interviews and spirometry of acceptable quality. COPD was defined according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria using postbronchodilator spirometry. The association of COPD with ETS in single and multiple settings was calculated by multivariate logistic regression adjusting for known risk factors for COPD.
RESULTS: COPD prevalence was associated with increased ETS exposure: 4.2% (no ETS), 8.0% (ETS ever at home), 8.3% (ETS at previous work), and 14.7% (ETS ever at home and at both previous and current work), test for trend P = .003. Exclusion of subjects aged ≥ 65 years and subjects reporting asthma yielded similar results. ETS in multiple settings, such as ever at home and at both previous and current work, was strongly associated to COPD (OR, 3.80; 95% CI, 1.29-11.2).
CONCLUSIONS: In this population-based sample of never smokers, ETS was independently associated with COPD. The association was stronger for ETS in multiple settings. ETS in multiple settings was, after age, the strongest risk factor for COPD and comparable to personal smoking of up to 14 cigarettes/d in comparable materials. The findings strongly advocate measures against smoking in public places.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24356778     DOI: 10.1378/chest.13-1349

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  39 in total

Review 1.  Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).

Authors:  Han Ni; Aung Htet; Soe Moe
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Passive smoking and chronic obstructive pulmonary disease mortality: findings from the Japan collaborative cohort study.

Authors:  Shigekazu Ukawa; Akiko Tamakoshi; Hiroshi Yatsuya; Kazumasa Yamagishi; Masahiko Ando; Hiroyasu Iso
Journal:  Int J Public Health       Date:  2017-02-17       Impact factor: 3.380

3.  Cigarette smoking in Austria - a call for action.

Authors:  David Celermajer; Subha Nasir-Ahmad
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

4.  Prognostic value of different scoring models in patients with multiple organ dysfunction syndrome associated with acute COPD exacerbation.

Authors:  Kun Xiao; Chao Guo; Longxiang Su; Peng Yan; Xin Li; Lixin Xie
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  Asthma, Chronic Obstructive Pulmonary Disease, and Subsequent Risk for Incident Rheumatoid Arthritis Among Women: A Prospective Cohort Study.

Authors:  Julia A Ford; Xinyi Liu; Su H Chu; Bing Lu; Michael H Cho; Edwin K Silverman; Karen H Costenbader; Carlos A Camargo; Jeffrey A Sparks
Journal:  Arthritis Rheumatol       Date:  2020-04-03       Impact factor: 10.995

6.  Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review.

Authors:  Syed H Haider; Assad Oskuei; George Crowley; Sophia Kwon; Rachel Lam; Jessica Riggs; Mena Mikhail; Angela Talusan; Arul Veerappan; James S Kim; Erin J Caraher; Anna Nolan
Journal:  Eur Respir Rev       Date:  2019-03-27

7.  COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.

Authors:  Wilson D Pace; Elias Brandt; Victoria A Carter; Ku-Lang Chang; Chelsea L Edwards; Alexander Evans; Chester Fox; Gabriela Gaona; MeiLan K Han; Alan G Kaplan; Rachel Kent; Janwillem W H Kocks; Maja Kruszyk; Chantal E Le Lievre; Tessa Li Voti; Cathy Mahle; Barry Make; Amanda R Ratigan; Asif Shaikh; Neil Skolnik; Brooklyn Stanley; Barbara P Yawn; David B Price
Journal:  Ann Fam Med       Date:  2022 Jul-Aug       Impact factor: 5.707

8.  Understanding the role of family dynamics, perceived norms, and lung cancer worry in predicting second-hand smoke avoidance among high-risk lung cancer families.

Authors:  Mark Manning; Mark Wojda; Lauren Hamel; Alicia Salkowski; Ann G Schwartz; Felicity Wk Harper
Journal:  J Health Psychol       Date:  2016-03-07

9.  Established and Emerging Environmental Contributors to Disparities in Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Jonathan I Levy; Lesliam Quirós-Alcalá; M Patricia Fabian; Komal Basra; Nadia N Hansel
Journal:  Curr Epidemiol Rep       Date:  2018-05-25

10.  Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).

Authors:  Han Ni; Soe Moe; Zay Soe; Kay Thi Myint; K Neelakantan Viswanathan
Journal:  Cochrane Database Syst Rev       Date:  2018-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.